Creating new tests to detect ovarian cancer early
Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms
This study is working on a new test to help find ovarian cancer early, which is really important for better treatment and survival, and it's designed to be accurate and affordable for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10850551 on NIH RePORTER |
What this research studies
This research focuses on developing innovative biomarkers that can help detect ovarian cancer at its earliest stages, which is crucial for improving survival rates. The approach involves creating a screening test that meets high sensitivity and specificity standards, potentially using a combination of biomarkers and imaging techniques. By utilizing computer models and preliminary findings, the research aims to establish a reliable and cost-effective method for early detection, which could lead to timely interventions for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are postmenopausal women who may be at risk for ovarian cancer.
Not a fit: Patients with advanced ovarian cancer or those who do not meet the risk criteria for screening may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce ovarian cancer mortality rates by enabling earlier diagnosis and treatment.
How similar studies have performed: Previous research has shown promise in developing early detection methods for ovarian cancer, but this approach aims to enhance existing strategies and is considered innovative.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Lokshin, Anna E. — University of Pittsburgh at Pittsburgh
- Study coordinator: Lokshin, Anna E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.